抗うつ薬の世界市場の洞察と2028年までの予測Global Anti-depressant Drugs Market Insights and Forecast to 2028 抗うつ剤は、大うつ病をはじめ、ジスキミア、不安障害、強迫性障害、摂食障害、慢性疼痛、神経因性疼痛、場合によっては月経困難症、いびき、片頭痛、注意欠陥多動性障害(ADHD)、中毒、依存、睡眠障害などの治... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー抗うつ剤は、大うつ病をはじめ、ジスキミア、不安障害、強迫性障害、摂食障害、慢性疼痛、神経因性疼痛、場合によっては月経困難症、いびき、片頭痛、注意欠陥多動性障害(ADHD)、中毒、依存、睡眠障害などの治療に用いられる薬剤です。これらの薬は、単独で処方されることもあれば、他の薬と組み合わせて処方されることもあります。市場分析と洞察。抗うつ薬の世界市場 COVID-19の流行により、抗うつ剤の世界市場規模は2022年に11910百万米ドル、2028年には13890百万米ドルになると予測されています(CAGR 2.6%)。この健康危機による経済的変化を十分に考慮して、選択的セロトニン再取り込み阻害剤(SSRI)は、2021年に抗うつ薬の世界市場の%を占めていましたが、2028年には100万米ドルになると予測され、COVID-19以降の期間に改訂された%のCAGRで成長しています。一方、大うつ病性障害のセグメントは、この予測期間を通じて%のCAGRで変化しています。 抗うつ薬市場:うつ病性障害(大うつ病、強迫性障害、全般性不安障害、パニック障害、その他)、製品別(三環系抗うつ薬、選択的セロトニン再取り込み阻害薬、セロトニン-ノルエピネフリン再取り込み阻害薬、モノアミン酸化酵素阻害薬、セロトニン拮抗薬および再取り込み阻害薬、その他)。 世界の抗うつ薬のスコープとセグメント 抗うつ薬市場は、タイプ別、アプリケーション別に分類されています。世界の抗うつ薬市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年の期間におけるタイプ別、アプリケーション別の売上高、収益、予測に焦点を当てています。 タイプ別セグメント 選択的セロトニン再取り込み阻害剤(SSRI) セロトニン・ノルエピネフリン再取り込み阻害剤(SNRI) 三環系抗うつ剤(TCA) モノアミン酸化酵素阻害剤(MAOI) その他 用途別セグメント 大うつ病性障害 強迫性障害(Obsessive-Compulsive Disorder) 全般性不安障害 パニック障害 その他 会社別 アルカーメス アラガン社 ブリストル・マイヤーズ スクイブ(Bristol-Myers Squibb イーライ・リリー・アンド・カンパニー グラクソ・スミスクライン(GlaxoSmithKline Lundbeck メルク ファイザー テバ・ファーマシューティカル・インダストリーズ 武田薬品工業 アストラゼネカ ジョンソン・アンド・ジョンソン サノフィ サン・ファーマシューティカルズ 地域別 北アメリカ U.S. カナダ ヨーロッパ ドイツ フランス イギリス イタリア ロシア アジアパシフィック 中国 日本 韓国 インド オーストラリア 台湾 インドネシア タイ マレーシア フィリピン ベトナム ラテンアメリカ メキシコ ブラジル アルゼンチン 中近東・アフリカ トルコ サウジアラビア U.A.E. 目次1 Study Coverage1.1 Anti-depressant Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Anti-depressant Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Selective Serotonin Reuptake Inhibitor (SSRI) 1.2.3 Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) 1.2.4 Tricyclic Antidepressant (TCA) 1.2.5 Monoamine Oxidase Inhibitor (MAOI) 1.2.6 Others 1.3 Market by Application 1.3.1 Global Anti-depressant Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Major Depressive Disorder 1.3.3 Obsessive-Compulsive Disorder 1.3.4 Generalized Anxiety Disorder 1.3.5 Panic Disorder 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Anti-depressant Drugs Sales Estimates and Forecasts 2017-2028 2.2 Global Anti-depressant Drugs Revenue Estimates and Forecasts 2017-2028 2.3 Global Anti-depressant Drugs Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Anti-depressant Drugs Sales by Region 2.4.1 Global Anti-depressant Drugs Sales by Region (2017-2022) 2.4.2 Global Sales Anti-depressant Drugs by Region (2023-2028) 2.5 Global Anti-depressant Drugs Revenue by Region 2.5.1 Global Anti-depressant Drugs Revenue by Region (2017-2022) 2.5.2 Global Anti-depressant Drugs Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Anti-depressant Drugs Sales by Manufacturers 3.1.1 Global Top Anti-depressant Drugs Manufacturers by Sales (2017-2022) 3.1.2 Global Anti-depressant Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-depressant Drugs in 2021 3.2 Global Anti-depressant Drugs Revenue by Manufacturers 3.2.1 Global Anti-depressant Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Global Anti-depressant Drugs Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Anti-depressant Drugs Revenue in 2021 3.3 Global Anti-depressant Drugs Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Anti-depressant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Anti-depressant Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Anti-depressant Drugs Sales by Type 4.1.1 Global Anti-depressant Drugs Historical Sales by Type (2017-2022) 4.1.2 Global Anti-depressant Drugs Forecasted Sales by Type (2023-2028) 4.1.3 Global Anti-depressant Drugs Sales Market Share by Type (2017-2028) 4.2 Global Anti-depressant Drugs Revenue by Type 4.2.1 Global Anti-depressant Drugs Historical Revenue by Type (2017-2022) 4.2.2 Global Anti-depressant Drugs Forecasted Revenue by Type (2023-2028) 4.2.3 Global Anti-depressant Drugs Revenue Market Share by Type (2017-2028) 4.3 Global Anti-depressant Drugs Price by Type 4.3.1 Global Anti-depressant Drugs Price by Type (2017-2022) 4.3.2 Global Anti-depressant Drugs Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Anti-depressant Drugs Sales by Application 5.1.1 Global Anti-depressant Drugs Historical Sales by Application (2017-2022) 5.1.2 Global Anti-depressant Drugs Forecasted Sales by Application (2023-2028) 5.1.3 Global Anti-depressant Drugs Sales Market Share by Application (2017-2028) 5.2 Global Anti-depressant Drugs Revenue by Application 5.2.1 Global Anti-depressant Drugs Historical Revenue by Application (2017-2022) 5.2.2 Global Anti-depressant Drugs Forecasted Revenue by Application (2023-2028) 5.2.3 Global Anti-depressant Drugs Revenue Market Share by Application (2017-2028) 5.3 Global Anti-depressant Drugs Price by Application 5.3.1 Global Anti-depressant Drugs Price by Application (2017-2022) 5.3.2 Global Anti-depressant Drugs Price Forecast by Application (2023-2028) 6 North America 6.1 North America Anti-depressant Drugs Market Size by Type 6.1.1 North America Anti-depressant Drugs Sales by Type (2017-2028) 6.1.2 North America Anti-depressant Drugs Revenue by Type (2017-2028) 6.2 North America Anti-depressant Drugs Market Size by Application 6.2.1 North America Anti-depressant Drugs Sales by Application (2017-2028) 6.2.2 North America Anti-depressant Drugs Revenue by Application (2017-2028) 6.3 North America Anti-depressant Drugs Market Size by Country 6.3.1 North America Anti-depressant Drugs Sales by Country (2017-2028) 6.3.2 North America Anti-depressant Drugs Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Anti-depressant Drugs Market Size by Type 7.1.1 Europe Anti-depressant Drugs Sales by Type (2017-2028) 7.1.2 Europe Anti-depressant Drugs Revenue by Type (2017-2028) 7.2 Europe Anti-depressant Drugs Market Size by Application 7.2.1 Europe Anti-depressant Drugs Sales by Application (2017-2028) 7.2.2 Europe Anti-depressant Drugs Revenue by Application (2017-2028) 7.3 Europe Anti-depressant Drugs Market Size by Country 7.3.1 Europe Anti-depressant Drugs Sales by Country (2017-2028) 7.3.2 Europe Anti-depressant Drugs Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Anti-depressant Drugs Market Size by Type 8.1.1 Asia Pacific Anti-depressant Drugs Sales by Type (2017-2028) 8.1.2 Asia Pacific Anti-depressant Drugs Revenue by Type (2017-2028) 8.2 Asia Pacific Anti-depressant Drugs Market Size by Application 8.2.1 Asia Pacific Anti-depressant Drugs Sales by Application (2017-2028) 8.2.2 Asia Pacific Anti-depressant Drugs Revenue by Application (2017-2028) 8.3 Asia Pacific Anti-depressant Drugs Market Size by Region 8.3.1 Asia Pacific Anti-depressant Drugs Sales by Region (2017-2028) 8.3.2 Asia Pacific Anti-depressant Drugs Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Anti-depressant Drugs Market Size by Type 9.1.1 Latin America Anti-depressant Drugs Sales by Type (2017-2028) 9.1.2 Latin America Anti-depressant Drugs Revenue by Type (2017-2028) 9.2 Latin America Anti-depressant Drugs Market Size by Application 9.2.1 Latin America Anti-depressant Drugs Sales by Application (2017-2028) 9.2.2 Latin America Anti-depressant Drugs Revenue by Application (2017-2028) 9.3 Latin America Anti-depressant Drugs Market Size by Country 9.3.1 Latin America Anti-depressant Drugs Sales by Country (2017-2028) 9.3.2 Latin America Anti-depressant Drugs Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Anti-depressant Drugs Market Size by Type 10.1.1 Middle East and Africa Anti-depressant Drugs Sales by Type (2017-2028) 10.1.2 Middle East and Africa Anti-depressant Drugs Revenue by Type (2017-2028) 10.2 Middle East and Africa Anti-depressant Drugs Market Size by Application 10.2.1 Middle East and Africa Anti-depressant Drugs Sales by Application (2017-2028) 10.2.2 Middle East and Africa Anti-depressant Drugs Revenue by Application (2017-2028) 10.3 Middle East and Africa Anti-depressant Drugs Market Size by Country 10.3.1 Middle East and Africa Anti-depressant Drugs Sales by Country (2017-2028) 10.3.2 Middle East and Africa Anti-depressant Drugs Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Alkermes 11.1.1 Alkermes Corporation Information 11.1.2 Alkermes Overview 11.1.3 Alkermes Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Alkermes Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Alkermes Recent Developments 11.2 Allergan 11.2.1 Allergan Corporation Information 11.2.2 Allergan Overview 11.2.3 Allergan Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Allergan Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Allergan Recent Developments 11.3 Bristol-Myers Squibb 11.3.1 Bristol-Myers Squibb Corporation Information 11.3.2 Bristol-Myers Squibb Overview 11.3.3 Bristol-Myers Squibb Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Bristol-Myers Squibb Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Bristol-Myers Squibb Recent Developments 11.4 Eli Lilly and Company 11.4.1 Eli Lilly and Company Corporation Information 11.4.2 Eli Lilly and Company Overview 11.4.3 Eli Lilly and Company Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Eli Lilly and Company Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Eli Lilly and Company Recent Developments 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Corporation Information 11.5.2 GlaxoSmithKline Overview 11.5.3 GlaxoSmithKline Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 GlaxoSmithKline Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 GlaxoSmithKline Recent Developments 11.6 Lundbeck 11.6.1 Lundbeck Corporation Information 11.6.2 Lundbeck Overview 11.6.3 Lundbeck Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Lundbeck Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Lundbeck Recent Developments 11.7 Merck 11.7.1 Merck Corporation Information 11.7.2 Merck Overview 11.7.3 Merck Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Merck Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Merck Recent Developments 11.8 Pfizer 11.8.1 Pfizer Corporation Information 11.8.2 Pfizer Overview 11.8.3 Pfizer Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Pfizer Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Pfizer Recent Developments 11.9 Teva Pharmaceutical Industries 11.9.1 Teva Pharmaceutical Industries Corporation Information 11.9.2 Teva Pharmaceutical Industries Overview 11.9.3 Teva Pharmaceutical Industries Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Teva Pharmaceutical Industries Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Teva Pharmaceutical Industries Recent Developments 11.10 Takeda Pharmaceutical Company 11.10.1 Takeda Pharmaceutical Company Corporation Information 11.10.2 Takeda Pharmaceutical Company Overview 11.10.3 Takeda Pharmaceutical Company Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Takeda Pharmaceutical Company Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Takeda Pharmaceutical Company Recent Developments 11.11 AstraZeneca 11.11.1 AstraZeneca Corporation Information 11.11.2 AstraZeneca Overview 11.11.3 AstraZeneca Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 AstraZeneca Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 AstraZeneca Recent Developments 11.12 Johnson and Johnson 11.12.1 Johnson and Johnson Corporation Information 11.12.2 Johnson and Johnson Overview 11.12.3 Johnson and Johnson Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 Johnson and Johnson Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Johnson and Johnson Recent Developments 11.13 Sanofi 11.13.1 Sanofi Corporation Information 11.13.2 Sanofi Overview 11.13.3 Sanofi Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 Sanofi Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 Sanofi Recent Developments 11.14 Sun Pharmaceuticals 11.14.1 Sun Pharmaceuticals Corporation Information 11.14.2 Sun Pharmaceuticals Overview 11.14.3 Sun Pharmaceuticals Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.14.4 Sun Pharmaceuticals Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 Sun Pharmaceuticals Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Anti-depressant Drugs Industry Chain Analysis 12.2 Anti-depressant Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Anti-depressant Drugs Production Mode & Process 12.4 Anti-depressant Drugs Sales and Marketing 12.4.1 Anti-depressant Drugs Sales Channels 12.4.2 Anti-depressant Drugs Distributors 12.5 Anti-depressant Drugs Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Anti-depressant Drugs Industry Trends 13.2 Anti-depressant Drugs Market Drivers 13.3 Anti-depressant Drugs Market Challenges 13.4 Anti-depressant Drugs Market Restraints 14 Key Findings in The Global Anti-depressant Drugs Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
SummaryAntidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications. Table of Contents1 Study Coverage1.1 Anti-depressant Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Anti-depressant Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Selective Serotonin Reuptake Inhibitor (SSRI) 1.2.3 Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) 1.2.4 Tricyclic Antidepressant (TCA) 1.2.5 Monoamine Oxidase Inhibitor (MAOI) 1.2.6 Others 1.3 Market by Application 1.3.1 Global Anti-depressant Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Major Depressive Disorder 1.3.3 Obsessive-Compulsive Disorder 1.3.4 Generalized Anxiety Disorder 1.3.5 Panic Disorder 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Anti-depressant Drugs Sales Estimates and Forecasts 2017-2028 2.2 Global Anti-depressant Drugs Revenue Estimates and Forecasts 2017-2028 2.3 Global Anti-depressant Drugs Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Anti-depressant Drugs Sales by Region 2.4.1 Global Anti-depressant Drugs Sales by Region (2017-2022) 2.4.2 Global Sales Anti-depressant Drugs by Region (2023-2028) 2.5 Global Anti-depressant Drugs Revenue by Region 2.5.1 Global Anti-depressant Drugs Revenue by Region (2017-2022) 2.5.2 Global Anti-depressant Drugs Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Anti-depressant Drugs Sales by Manufacturers 3.1.1 Global Top Anti-depressant Drugs Manufacturers by Sales (2017-2022) 3.1.2 Global Anti-depressant Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-depressant Drugs in 2021 3.2 Global Anti-depressant Drugs Revenue by Manufacturers 3.2.1 Global Anti-depressant Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Global Anti-depressant Drugs Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Anti-depressant Drugs Revenue in 2021 3.3 Global Anti-depressant Drugs Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Anti-depressant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Anti-depressant Drugs Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Anti-depressant Drugs Sales by Type 4.1.1 Global Anti-depressant Drugs Historical Sales by Type (2017-2022) 4.1.2 Global Anti-depressant Drugs Forecasted Sales by Type (2023-2028) 4.1.3 Global Anti-depressant Drugs Sales Market Share by Type (2017-2028) 4.2 Global Anti-depressant Drugs Revenue by Type 4.2.1 Global Anti-depressant Drugs Historical Revenue by Type (2017-2022) 4.2.2 Global Anti-depressant Drugs Forecasted Revenue by Type (2023-2028) 4.2.3 Global Anti-depressant Drugs Revenue Market Share by Type (2017-2028) 4.3 Global Anti-depressant Drugs Price by Type 4.3.1 Global Anti-depressant Drugs Price by Type (2017-2022) 4.3.2 Global Anti-depressant Drugs Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Anti-depressant Drugs Sales by Application 5.1.1 Global Anti-depressant Drugs Historical Sales by Application (2017-2022) 5.1.2 Global Anti-depressant Drugs Forecasted Sales by Application (2023-2028) 5.1.3 Global Anti-depressant Drugs Sales Market Share by Application (2017-2028) 5.2 Global Anti-depressant Drugs Revenue by Application 5.2.1 Global Anti-depressant Drugs Historical Revenue by Application (2017-2022) 5.2.2 Global Anti-depressant Drugs Forecasted Revenue by Application (2023-2028) 5.2.3 Global Anti-depressant Drugs Revenue Market Share by Application (2017-2028) 5.3 Global Anti-depressant Drugs Price by Application 5.3.1 Global Anti-depressant Drugs Price by Application (2017-2022) 5.3.2 Global Anti-depressant Drugs Price Forecast by Application (2023-2028) 6 North America 6.1 North America Anti-depressant Drugs Market Size by Type 6.1.1 North America Anti-depressant Drugs Sales by Type (2017-2028) 6.1.2 North America Anti-depressant Drugs Revenue by Type (2017-2028) 6.2 North America Anti-depressant Drugs Market Size by Application 6.2.1 North America Anti-depressant Drugs Sales by Application (2017-2028) 6.2.2 North America Anti-depressant Drugs Revenue by Application (2017-2028) 6.3 North America Anti-depressant Drugs Market Size by Country 6.3.1 North America Anti-depressant Drugs Sales by Country (2017-2028) 6.3.2 North America Anti-depressant Drugs Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Anti-depressant Drugs Market Size by Type 7.1.1 Europe Anti-depressant Drugs Sales by Type (2017-2028) 7.1.2 Europe Anti-depressant Drugs Revenue by Type (2017-2028) 7.2 Europe Anti-depressant Drugs Market Size by Application 7.2.1 Europe Anti-depressant Drugs Sales by Application (2017-2028) 7.2.2 Europe Anti-depressant Drugs Revenue by Application (2017-2028) 7.3 Europe Anti-depressant Drugs Market Size by Country 7.3.1 Europe Anti-depressant Drugs Sales by Country (2017-2028) 7.3.2 Europe Anti-depressant Drugs Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Anti-depressant Drugs Market Size by Type 8.1.1 Asia Pacific Anti-depressant Drugs Sales by Type (2017-2028) 8.1.2 Asia Pacific Anti-depressant Drugs Revenue by Type (2017-2028) 8.2 Asia Pacific Anti-depressant Drugs Market Size by Application 8.2.1 Asia Pacific Anti-depressant Drugs Sales by Application (2017-2028) 8.2.2 Asia Pacific Anti-depressant Drugs Revenue by Application (2017-2028) 8.3 Asia Pacific Anti-depressant Drugs Market Size by Region 8.3.1 Asia Pacific Anti-depressant Drugs Sales by Region (2017-2028) 8.3.2 Asia Pacific Anti-depressant Drugs Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Anti-depressant Drugs Market Size by Type 9.1.1 Latin America Anti-depressant Drugs Sales by Type (2017-2028) 9.1.2 Latin America Anti-depressant Drugs Revenue by Type (2017-2028) 9.2 Latin America Anti-depressant Drugs Market Size by Application 9.2.1 Latin America Anti-depressant Drugs Sales by Application (2017-2028) 9.2.2 Latin America Anti-depressant Drugs Revenue by Application (2017-2028) 9.3 Latin America Anti-depressant Drugs Market Size by Country 9.3.1 Latin America Anti-depressant Drugs Sales by Country (2017-2028) 9.3.2 Latin America Anti-depressant Drugs Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Anti-depressant Drugs Market Size by Type 10.1.1 Middle East and Africa Anti-depressant Drugs Sales by Type (2017-2028) 10.1.2 Middle East and Africa Anti-depressant Drugs Revenue by Type (2017-2028) 10.2 Middle East and Africa Anti-depressant Drugs Market Size by Application 10.2.1 Middle East and Africa Anti-depressant Drugs Sales by Application (2017-2028) 10.2.2 Middle East and Africa Anti-depressant Drugs Revenue by Application (2017-2028) 10.3 Middle East and Africa Anti-depressant Drugs Market Size by Country 10.3.1 Middle East and Africa Anti-depressant Drugs Sales by Country (2017-2028) 10.3.2 Middle East and Africa Anti-depressant Drugs Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Alkermes 11.1.1 Alkermes Corporation Information 11.1.2 Alkermes Overview 11.1.3 Alkermes Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Alkermes Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Alkermes Recent Developments 11.2 Allergan 11.2.1 Allergan Corporation Information 11.2.2 Allergan Overview 11.2.3 Allergan Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Allergan Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Allergan Recent Developments 11.3 Bristol-Myers Squibb 11.3.1 Bristol-Myers Squibb Corporation Information 11.3.2 Bristol-Myers Squibb Overview 11.3.3 Bristol-Myers Squibb Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Bristol-Myers Squibb Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Bristol-Myers Squibb Recent Developments 11.4 Eli Lilly and Company 11.4.1 Eli Lilly and Company Corporation Information 11.4.2 Eli Lilly and Company Overview 11.4.3 Eli Lilly and Company Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Eli Lilly and Company Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Eli Lilly and Company Recent Developments 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Corporation Information 11.5.2 GlaxoSmithKline Overview 11.5.3 GlaxoSmithKline Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 GlaxoSmithKline Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 GlaxoSmithKline Recent Developments 11.6 Lundbeck 11.6.1 Lundbeck Corporation Information 11.6.2 Lundbeck Overview 11.6.3 Lundbeck Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Lundbeck Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Lundbeck Recent Developments 11.7 Merck 11.7.1 Merck Corporation Information 11.7.2 Merck Overview 11.7.3 Merck Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Merck Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Merck Recent Developments 11.8 Pfizer 11.8.1 Pfizer Corporation Information 11.8.2 Pfizer Overview 11.8.3 Pfizer Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Pfizer Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Pfizer Recent Developments 11.9 Teva Pharmaceutical Industries 11.9.1 Teva Pharmaceutical Industries Corporation Information 11.9.2 Teva Pharmaceutical Industries Overview 11.9.3 Teva Pharmaceutical Industries Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Teva Pharmaceutical Industries Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Teva Pharmaceutical Industries Recent Developments 11.10 Takeda Pharmaceutical Company 11.10.1 Takeda Pharmaceutical Company Corporation Information 11.10.2 Takeda Pharmaceutical Company Overview 11.10.3 Takeda Pharmaceutical Company Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Takeda Pharmaceutical Company Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Takeda Pharmaceutical Company Recent Developments 11.11 AstraZeneca 11.11.1 AstraZeneca Corporation Information 11.11.2 AstraZeneca Overview 11.11.3 AstraZeneca Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.11.4 AstraZeneca Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.11.5 AstraZeneca Recent Developments 11.12 Johnson and Johnson 11.12.1 Johnson and Johnson Corporation Information 11.12.2 Johnson and Johnson Overview 11.12.3 Johnson and Johnson Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.12.4 Johnson and Johnson Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.12.5 Johnson and Johnson Recent Developments 11.13 Sanofi 11.13.1 Sanofi Corporation Information 11.13.2 Sanofi Overview 11.13.3 Sanofi Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.13.4 Sanofi Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.13.5 Sanofi Recent Developments 11.14 Sun Pharmaceuticals 11.14.1 Sun Pharmaceuticals Corporation Information 11.14.2 Sun Pharmaceuticals Overview 11.14.3 Sun Pharmaceuticals Anti-depressant Drugs Sales, Price, Revenue and Gross Margin (2017-2022) 11.14.4 Sun Pharmaceuticals Anti-depressant Drugs Product Model Numbers, Pictures, Descriptions and Specifications 11.14.5 Sun Pharmaceuticals Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Anti-depressant Drugs Industry Chain Analysis 12.2 Anti-depressant Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Anti-depressant Drugs Production Mode & Process 12.4 Anti-depressant Drugs Sales and Marketing 12.4.1 Anti-depressant Drugs Sales Channels 12.4.2 Anti-depressant Drugs Distributors 12.5 Anti-depressant Drugs Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Anti-depressant Drugs Industry Trends 13.2 Anti-depressant Drugs Market Drivers 13.3 Anti-depressant Drugs Market Challenges 13.4 Anti-depressant Drugs Market Restraints 14 Key Findings in The Global Anti-depressant Drugs Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(中枢神経系作用薬)の最新刊レポート
QYResearch社の中枢神経系作用薬分野での最新刊レポート
本レポートと同じKEY WORD(antidepressant)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |